Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prolight Diagnostics ABNGM:PRLD -6.35%30 Price-to-Tangible-Book is 29.97 as of Sep. 21, 2026. GuruFocus rates NGM:PRLD with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 703 Medical Devices & Instruments companies, Prolight Diagnostics AB ranks worse than 97.01% on this metric.
The historical rank and industry rank for Prolight Diagnostics AB's Price-to-Tangible-Book or its related term are showing as below:
NGM:PRLD'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1 Med: 5.84 Max: 123.49
Current: 29.97
During the past 10 years, Prolight Diagnostics AB's highest Price to Tangible Book Ratio was 123.49. The lowest was 1.00. And the median was 5.84.
NGM:PRLD's Price-to-Tangible-Book is ranked worse than 97.01% of 703
companies
in the Medical Devices & Instruments industry
Industry Median: 2.7
vs NGM:PRLD: 29.97
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Prolight Diagnostics AB Price-to-Tangible-Book Related Terms
Prolight Diagnostics AB Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Prolight Diagnostics AB's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prolight Diagnostics AB Price-to-Tangible-Book Chart
NGM:PRLD vs ISRG, BDX, RMD: Price-to-Tangible-Book Comparison
For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prolight Diagnostics AB Price-to-Tangible-Book vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Prolight Diagnostics AB's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Prolight Diagnostics AB (NGM:PRLD) has a Price-to-Tangible-Book of 29.97 as of Sep. 21, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Prolight Diagnostics AB and its competitors. According to the industry distribution chart, Prolight Diagnostics AB ranks #682 out of 703 companies in the Medical Devices & Instruments industry, placing it in the top 97%.
Is Prolight Diagnostics AB's Price-to-Tangible-Book too high?
Prolight Diagnostics AB's current Price-to-Tangible-Book is 29.97. The Medical Devices & Instruments industry median Price-to-Tangible-Book is 2.70. Prolight Diagnostics AB's value of 29.97 is 1010% above this industry median. Based on the distribution chart, Prolight Diagnostics AB ranks #682 out of 703 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Prolight Diagnostics AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Prolight Diagnostics AB's Price-to-Tangible-Book compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prolight Diagnostics AB ranks #682 out of 703 companies for Price-to-Tangible-Book. This places Prolight Diagnostics AB in the lower half of its industry. The industry median Price-to-Tangible-Book is 2.70. Prolight Diagnostics AB's value of 29.97 is 1010% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Devices & Instruments company?
The median Price-to-Tangible-Book among Medical Devices & Instruments companies is 2.70, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prolight Diagnostics AB's current Price-to-Tangible-Book of 29.97 is 1010% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Prolight Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median Price-to-Tangible-Book is 2.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prolight Diagnostics AB's current Price-to-Tangible-Book is 29.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolight Diagnostics AB stock overvalued right now?
Prolight Diagnostics AB (NGM:PRLD) has a current Price-to-Tangible-Book of 29.97. The current Price-to-Tangible-Book is 29.97 and 1010% above the Medical Devices & Instruments industry median of 2.70. Prolight Diagnostics AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Prolight Diagnostics AB (NGM:PRLD), the current Price-to-Tangible-Book is 29.97 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
30GF Score
Get the complete analysis for NGM:PRLD
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:PRLD has been successfully added to your 
